Zobrazeno 1 - 10
of 53
pro vyhledávání: '"K Theede"'
Autor:
M Attauabi, G R Madsen, F Bendtsen, J T Bjerrum, R Wilkens, K Theede, J F K F Ilvemark, T Boysen, J B Seidelin, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 17:i437-i440
Background The initial disease burden of Crohn’s disease (CD) is dissimilar across patients; however, the ability to capture and predict the disease burden at diagnosis is scarcely investigated. The aim of the current study was to describe the init
Autor:
M Attauabi, J F Dahlerup, A Poulsen, M R Hansen, M K Vester-Andersen, S Eraslan, A P Prahm, N Pedersen, L Larsen, T Jess, A Neumann, K V Haderslev, A Molazahi, A B Lødrup, H Glerup, A M Oppfeldt, M D Jensen, K Theede, M Kiszka-Kanowitz, J B Seidelin, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i562-i565
Background The coronavirus disease 2019 (COVID-19) pandemic raised concerns among patients with ulcerative colitis (UC) and Crohn’s disease (CD) fearing an increased susceptibility to infection and increased risk of poor outcomes. Furthermore, the
Autor:
G R Madsen, M Attauabi, R Wilkens, J F K F Ilvemark, K Theede, J T Bjerrum, F Bendtsen, J B Seidelin, T Boysen, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 17:i317-i318
Background The disease course of inflammatory bowel disease (IBD) is heterogeneous and unpredictable. Currently, we are unable to predict which patients will need IBD-related bowel resection in the first year after diagnosis. Intestinal Ultrasound (I
Autor:
M Attauabi, G R Madsen, F Bendtsen, R Wilkens, J F K F Ilvemark, K Theede, T Boysen, J T Bjerrum, J B Seidelin, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i285-i287
Background The early course of ulcerative colitis (UC) and Crohn’s disease (CD) is difficult to predict, particularly regarding identifying patients for whom an indolent course might be expected. Therefore, we aimed to investigate the initial cours
Autor:
M Attauabi, J F Dahlerup, A Poulsen, M R Hansen, M K Vester-Andersen, S Eraslan, A P Prahm, N Pedersen, L Larsen, T Jess, A Neumann, K V Haderslev, A Molazahi, A B Lødrup, H Glerup, A M Oppfeldt, M D Jensen, K Theede, M Kiszka-Kanowitz, J B Seidelin, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i072-i074
Background The vast majority of patients with ulcerative colitis (UC) and Crohn’s disease (CD) who acquire coronavirus disease 2019 (COVID-19) survive the infection. Still, the long-term health consequences of COVID-19 are not well described in pat
Autor:
M Attauabi, J F Dahlerup, A Poulsen, M Rosager Hansen, M K Vester-Andersen, S Eraslan, A P Prahm, N Pedersen, L Larsen, T Jess, A Neumann, K V Haderslev, A Molazahi, A B Lødrup, H Glerup, A M Oppfeldt, M D Jensen, K Theede, M Kiszka-Kanowitz, J B Seidelin, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i587-i589
Background Population-based data regarding outcomes of coronavirus disease 2019 (COVID-19) among patients with ulcerative colitis (UC) and Crohn’s disease (CD) remain limited. Methods We conducted a population-based study investigating the outcomes
Autor:
M Dorn-Rasmussen, M Attauabi, G R Madsen, A V Wewer, S Jansson, M M Knudsen, R Wilkens, J F K F Ilvemark, J W Bjerrum, K Theede, F Bendtsen, B Trine, J B Seidelin, J M Burisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i556-i557
Background Denmark has one of the highest occurrences of inflammatory bowel disease (IBD) in the world, with reported incidence rates of 7.2 and 6.2 in paediatric ulcerative colitis (pUC) and 10 and 9.4 per 105 for girls and boys in Crohn’s disease
Autor:
M D Wewer, L Arp, S Melek, F Oluf Krautwald, I Vind, G Pedersen, A M Nielsen, M Kiszka-Kanowitz, T Boysen, K Theede, I Nordgaard-Lassen, F Bendtsen, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i053-i054
Background Direct health care costs have shifted towards drug-related expenditures in patients with inflammatory bowel disease (IBD). Frequently, patients will have to switch to a second- or third-line biological therapy due to no response or loss of
Autor:
M Attauabi, J F Dahlerup, A Poulsen, M R Hansen, M K Vester-Andersen, S Eraslan, A P Prahm, N Pedersen, L Larsen, T Jess, A Neumann, K V Haderslev, A Molazahi, A B Lødrup, H Glerup, A M Oppfeldt, M D Jensen, K Theede, M Kiszka-Kanowitz, J B Seidelin, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i071-i072
Background Whether the disease activity of ulcerative colitis (UC) and Crohn’s disease (CD) is correlated with the severity of coronavirus disease 2019 (COVID-19) remains poorly investigated with only few selected cohort studies having addressed th
Autor:
G R Madsen, M Attauabi, R Wilkens, J F K F Ilvemark, K Theede, J T Bjerrum, M Dorn-Rasmussen, S Jansson, A V Wewer, F Bendtsen, J B Seidelin, T Boysen, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i059-i060
Background The disease course of inflammatory bowel disease (IBD) is heterogeneous and highly unpredictable. Intestinal Ultrasound (IUS) is a non-invasive modality capable of assessing disease activity in IBD. IUS is reliable, patient-friendly, and a